Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Short Interest Update

Curaleaf Holdings, Inc. (OTCMKTS:CURLFGet Free Report) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 6,337,300 shares, a drop of 9.0% from the January 15th total of 6,962,300 shares. Based on an average daily trading volume, of 1,348,400 shares, the short-interest ratio is presently 4.7 days.

Curaleaf Stock Performance

Shares of OTCMKTS CURLF traded down $0.02 during mid-day trading on Monday, hitting $1.48. The company had a trading volume of 406,433 shares, compared to its average volume of 791,787. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $971.01 million, a price-to-earnings ratio of -5.10 and a beta of 0.60. Curaleaf has a 1 year low of $0.88 and a 1 year high of $6.40. The stock’s 50-day moving average price is $1.50 and its 200-day moving average price is $2.35.

Analysts Set New Price Targets

A number of brokerages have commented on CURLF. Roth Capital raised Curaleaf to a “strong-buy” rating in a report on Sunday, November 10th. Cormark downgraded Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday, November 7th.

Check Out Our Latest Stock Analysis on CURLF

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.